资讯
TG Therapeutics, Inc.'s BRIUMVI saw Q1 2025 revenue surge 137% YoY. Click to learn about TGTX growth, upcoming trials, and ...
The European Commission (EC) has approved argenx’s Vyvgart (efgartigimod alfa) subcutaneous (SC) injection to treat chronic ...
Therapy in relapsing polychondritis is confined at the present time to the continuous use of corticosteroids. We have used prednisone, 30 mg. daily in divided doses, to control the acute disease.
Relapsing Polychondritis Causes. Doctors don’t know what causes RP. Some think a certain gene may make you more likely to get it, but it doesn’t run in families.
Relapses are a defining feature of relapsing-remitting MS (RRMS), which is the most common form of the condition. RRMS is the initial diagnosis for 85 percent of people with MS. [1] ...
Lapsing and relapsing addicts behave as they do because there has been a larger deterioration in their life. The decision to abuse a substance is simply the final step before they hit the bottom.
Relapsing polychondritis is a rare degenerative condition with no cure. Treatment typically focuses on addressing symptoms and slowing the progression of the condition. Relapsing polychondritis is ...
Though there’s no cure for multiple sclerosis, there are many new treatment options aimed at slowing its progression, decreasing symptoms, and improving mental and physical function. Multiple ...
当前正在显示可能无法访问的结果。
隐藏无法访问的结果